National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
SODIUM BICARBONATE INJECTION , USP
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00074-5534-34 | 23281 | A | 3 | 2 | 4 | ZZ | ||
| 03-1834 | 89875 | A | 5 | 1 | 4 | ZZ | ||
| NDC00074-5534-18 | 70048 | A | 3 | 2 | 4 | ZZ | ||
| NDC00074-5534-34 | 70048 | A | 3 | 2 | 4 | ZZ | ||
| NDC00074-5534-34 | 60060 | A | 5 | 2 | 4 | ZZ | ||
| NDC00409-5534-34 | 3VBU6 | A | 3 | 2 | 4 | ZZ | ||
| 6505NCM031541 | 64616 | A | 5 | 1 | 4 | ZZ | ||
| SODIUM BICARBONATE | 70048 | A | 5 | 1 | 4 | ZZ | ||
| NDC00074-5534-18 | 23281 | A | 3 | 2 | 4 | ZZ |
CAGE Information
| Code | Company |
|---|---|
| 23281 | ABBOTT LABORATORIES INC ROSS PRODUCT |
| 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE |
| 70048 | ABBOTT LABORATORIES PHARMACEUTICAL P |
| 60060 | ABBOTT LABORATORIES INC. DIV HOSPITA |
| 3VBU6 | HOSPIRA INC. |
| 64616 | DEFENSE MEDICAL STANDARDIZATION BOAR |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CBBL | FEATURES PROVIDED | STERILE |
| AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 400800 |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | SODIUM BICARBONATE 42 MG/ML INJECTION 10S |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 4.200 PERCENTAGE, W/V SODIUM BICARBONATE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | SYRINGE |
| FEAT | SPECIAL FEATURES | 0.5 MEQ/ML; 10ML DISPOSABLE SYRINGE; STORE AT CONTROLLED ROOM TEMP 15 TO 30 DEG C (59 TO 86 DEG F); FOR CORRECTION OF METABOLIC ACIDOSIS AND OTHER CONDITIONS REQUIRING SYSTEMIC ALKALINIZATION |
| CSGS | ADMINISTRATION | INTRAVENOUS |